February 16, 2021

iBiopsy®: Median Technologies Continues Its Strong Positioning in Early-Stage Diagnosis with a New iBiopsy® Clinical Development Plan on Lung Cancer Screening (LCS)

SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)—- $ALMDT #IA–iBiopsy®: Median Technologies continues its strong positioning in early-stage diagnosis


Leave Comment


Your Name *
Your Email *
Your Website
Comment *